TECH
BIO-TECHNE Corp
+0.08 (+0.11%)72.41USD1.6M成交股數11.4B市值62.4本益比(近四季)9.3股價營收比-1.5%營收年增(近四季)2026-11-09下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 6 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q4 | 26Q3 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 321M+2% | 311M+5% | 296M+2% | 287M-6% | 316M+4% | 297M+9% | 289M+5% | 306M+4% | 303M | 273M | 277M | 294M |
| 營業成本 | 110M | 103M | 105M | 98.4M | 102M | 103M | 106M | 103M | 98.8M | 96.0M | 91.7M | 92.0M |
| 毛利 | 211M-1% | 208M+7% | 191M+5% | 188M-7% | 215M+5% | 194M+10% | 183M-1% | 203M+1% | 205M | 177M | 185M | 202M |
| 毛利率 | 65.8% | 66.9% | 64.6% | 65.6% | 67.9% | 65.3% | 63.2% | 66.4% | 67.4% | 64.8% | 66.9% | 68.7% |
| 研發費用 | 23.9M | 23.5M | 23.1M | 24.2M | 24.6M | 25.0M | 23.9M | 24.0M | 25.8M | 22.9M | 24.0M | 22.7M |
| 銷售管理費用 | 113M | 109M | 114M | 116M | 151M | 121M | 119M | 134M | 112M | 116M | 105M | 99.2M |
| 營業利益 | 74.3M+92% | 75.5M+59% | 54.5M+36% | 47.7M+4% | 38.7M-42% | 47.4M+25% | 40.0M-28% | 45.8M-43% | 67.0M | 38.0M | 55.9M | 80.2M |
| 營業利益率 | 23.1% | 24.2% | 18.4% | 16.6% | 12.2% | 16.0% | 13.8% | 15.0% | 22.1% | 13.9% | 20.2% | 27.3% |
| 稅後淨利 | 54.6M+142% | 51.0M+46% | 38.0M+13% | 38.2M-6% | 22.6M-54% | 34.9M+27% | 33.6M-34% | 40.6M-42% | 49.1M | 27.5M | 51.0M | 70.2M |
| 淨利率 | 17.0% | 16.4% | 12.8% | 13.3% | 7.1% | 11.7% | 11.6% | 13.3% | 16.2% | 10.1% | 18.4% | 23.9% |
| 稀釋 EPS | 0.36+157% | 0.32+45% | 0.24+14% | 0.24-8% | 0.14-55% | 0.22+29% | 0.21-32% | 0.26-40% | 0.31 | 0.17 | 0.31 | 0.43 |
| 稀釋股數 | 157M | 157M | 157M | 156M | 159M | 161M | 161M | 161M | 160M | 160M | 162M | 162M |
資產負債表 期末餘額
| 科目 | 26Q4 | 26Q3 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 265M | 210M | 173M | 145M | 141M | 178M | 188M | 152M | 140M | 130M | 149M | 127M |
| 應收帳款 | 217M | 215M | 185M | 184M | 237M | 218M | 224M | 241M | 228M | 207M | 205M | 216M |
| 存貨 | 196M | 201M | 205M | 203M | 191M | 188M | 185M | 180M | 179M | 181M | 186M | 169M |
| 總資產 | 2.6B | 2.6B | 2.5B | 2.5B | 2.6B | 2.7B | 2.7B | 2.7B | 2.7B | 2.7B | 2.8B | 2.6B |
| 有息負債 | 200M | 200M | 260M | 300M | 330M | 300M | 300M | 319M | 389M | 447M | 440M | 370M |
| 總負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 股東權益 | 2.1B | 2.1B | 2.0B | 2.0B | 2.0B | 2.1B | 2.1B | 2.1B | 2.0B | 2.0B | 2.0B | 1.9B |
| 負債比 | – | – | – | – | – | – | – | – | – | – | – | – |
| 淨現金(現金 − 有息負債) | 64.7M | 9.8M | −87.1M | −155M | −189M | −122M | −112M | −167M | −249M | −317M | −291M | −243M |
現金流量表 單季
| 科目 | 26Q4 | 26Q3 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | – | – | 27.6M | – | – | 63.9M+8% | – | – | – | 59.4M | – |
| 資本支出 | – | – | – | 5.4M | – | – | 9.2M | – | – | – | 13.6M | – |
| 自由現金流 | – | – | – | 22.2M | – | – | 54.7M+19% | – | – | – | 45.8M | – |
| 折舊攤銷 | – | – | – | 24.3M | – | – | 28.1M | – | – | – | 28.5M | – |
| 買回庫藏股 | – | – | – | 24K | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | 12.4M | – | – | 12.7M | – | – | – | 12.7M | – |
| 自由現金流率 | – | – | – | 7.8% | – | – | 18.9% | – | – | – | 16.5% | – |
營收拆解 2026 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2026 年度 · 1.2B
| Protein Sciences | 875M | 72.2% | +0.5% |
|---|---|---|---|
| Diagnostics And Spatial Biology | 336M | 27.8% | -2.9% |
地區2026 年度 · 1.2B
| 美國 | 635M | 52.3% | -7.0% |
|---|---|---|---|
| EMEA Excluding UK | 294M | 24.2% | +10.5% |
| 中國 | 104M | 8.6% | +3.6% |
| APAC Excluding Greater China | 85.8M | 7.1% | +11.1% |
| 英國 | 56.3M | 4.6% | +2.7% |
| 其他地區 | 39.3M | 3.2% | +4.6% |
產品／服務2026 年度 · 1.2B
| Consumables | 985M | 81.1% | +1.3% |
|---|---|---|---|
| Instruments | 111M | 9.1% | -1.3% |
| 服務 | 94.3M | 7.8% | -15.5% |
| Royalty | 25.0M | 2.1% | +5.5% |
| Product And Services 小計 | 1.2B | 97.9% | -0.5% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2026 | 1.2B | -0.4% | 182M | 15.0% | 1.16 | 263M |
| FY2025 | 1.2B | +5.2% | 73.4M | 6.0% | 0.46 | 257M |
| FY2024 | 1.2B | +2.0% | 168M | 14.5% | 1.05 | 236M |
| FY2023 | 1.1B | +2.8% | 285M | 25.1% | 1.76 | 216M |
| FY2022 | 1.1B | +18.7% | 272M | 24.6% | 1.66 | 280M |
| FY2021 | 931M | +26.0% | 140M | 15.1% | 0.87 | 308M |
| FY2020 | 739M | +3.5% | 229M | 31.0% | 5.82 | 153M |
| FY2019 | 714M | – | 96.1M | 13.5% | 2.47 | 156M |